NUTRA PHARMA CORP. Deferred Tax Assets, Operating Loss Carryforwards
NUTRA PHARMA CORP. (NPHC) had Deferred Tax Assets, Operating Loss Carryforwards of $8.62 million as of 2025-12-31, per its 10-K filed 2026-05-20.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-05-20
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $8.62M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $9.13M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $11.23M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $11.00M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $8.62M 10-K · filed 2026-05-20 | |
| 2024-12-31 | $9.13M 10-K · filed 2026-05-20 | |
| 2023-12-31 | $11.23M 10-K · filed 2026-02-17 | |
| 2022-12-31 | $11.00M 10-K · filed 2025-11-24 | |
| 2021-12-31 | $10.35M 10-K · filed 2025-09-03 | |
| 2020-12-31 | $9.73M 10-K · filed 2022-04-15 | |
| 2019-12-31 | $9.40M 10-K · filed 2021-09-08 | |
| 2018-12-31 | $9.08M 10-K · filed 2021-07-01 | |
| 2017-12-31 | $12.79M 10-K · filed 2021-02-05 | |
| 2016-12-31 | $12.67M 10-K · filed 2018-04-17 | |
| 2015-12-31 | $12.14M 10-K · filed 2017-04-17 | |
| 2014-12-31 | $10.74M 10-K · filed 2015-04-13 | |
| 2013-12-31 | $10.58M 10-K · filed 2015-04-13 | $6.23M 10-K · filed 2014-03-31 |
| 2012-12-31 | $5.58M 10-K · filed 2014-03-31 | |
| 2011-12-31 | $4.98M 10-K · filed 2013-04-16 |